Stocks were little changed Wednesday, as the Dow and the S&P flirted with gains after two a two-day drop.» Read More
Some of the names on the move ahead of the open.
SEC's Director of Enforcement, Robert Khuzami responds to rumor of Herbalife inquiry.
Bank of America was the biggest gainer in the Dow in 2012, and the Fast Money traders discuss how to play the stock now; and everything you need to know about Herbalife's stock, with CNBC's Herb Greenberg.
Stocks ended higher in thin trading Wednesday, after Dow component Alcoa kicked off the fourth-quarter earnings season on a positive note.
Check out which companies are making headlines after the bell Wednesday:
Multi-level marketers were a key target of the FTC's Business Opportunity Rule when it was originally proposed. But it turns out the new rule doesn't cover MLMs.
Multi-level marketing is a form of knocking on doors and making calls to directly pitch a product to a customer. But not every company admits to being a direct seller.
Dow Jones is now reporting that the SEC has opened an inquiry into Herbalife, with CNBC's Herb Greenberg.
The trouble, according to Joe Mariano, president of the Direct Selling Association, that "there are a lot of pyramid schemes that like to disguise themselves as legitimate direct-selling companies."
Multi-level marketing critic Robert Fitzpatrick talks about pyramid schemes and the MLM industry.
Third Point's Dan Loeb has taken a long position in Herbalife, according to a regulatory filing.
Multi-level marketers get a pass from regulators, critics say. Are consumers on the losing end?
The story of the guy who started it all.
The multi-level marketing sales pitch may not be for everyone. Former distributors speak up.
Multi-level marketing is a big business, but one critic says it's also a big lie.
MLM sales pitch may not be for everybody. Former Herbalife distributors share their stories.
After a 10-month investigation, CNBC found many people who had trouble selling Herbalife and sometimes lost thousands of dollars in the process. Herbalife's stock is now in the middle of a major hedge fund battle.
Take a look at some of Wednesday's midday movers:
CNBC's Herb Greenberg and Gary Kaminsky share their perspective on the battle looming between titans Dan Loeb and Bill Ackman over Herbalife.